>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Continues Participation in SGR Reform Discussion

Tuesday, June 11, 2013

On June 11, ASA responded to the latest request for additional feedback from the U.S. House Committee on Energy and Commerce regarding their ongoing proposal to repeal and replace the Medicare Sustainable Growth Rate (SGR) formula.

ASA's response built off previous comments that state an important precursor to the development of any form of SGR repeal and replacement is "acknowledgment and remedy" of anesthesiology's "33 percent problem." 

In response to the Committee's questions, ASA also advocated for five years or more of payment stability prior to the implementation of any new system and that a mechanism be created to extend the period if there is "a lack of developed measures or inadequate quality infrastructure."  

ASA remains committed to repealing and replacing the flawed SGR mechanism with a system that more accurately reflects the cost of providing care to Medicare patients. 

Review ASA's June 11 response to the Committee on Energy and Commerce.
Review ASA's April response.
Review ASA's February response.

« Back to Washington Alerts